You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for 1199SEIU National Benefit Fund v. Boehringer Ingelheim Pharmaceuticals, Inc. (D. Conn. 2024)

✉ Email this page to a colleague

« Back to Dashboard

1199SEIU National Benefit Fund v. Boehringer Ingelheim Pharmaceuticals, Inc. (D. Conn. 2024)

Docket	⤷ Sign Up	Date Filed	2024-04-29
Court	District Court, D. Connecticut	Date Terminated
Cause	15:15 Antitrust Litigation	Assigned To	Alvin W. Thompson
Jury Demand	Plaintiff	Referred To	Maria E. Garcia
Patents	7,284,474; 7,396,341; 7,837,235; 7,896,264; 8,733,341; 9,027,967
Link to Docket	External link to docket

Small Molecule Drugs cited in 1199SEIU National Benefit Fund v. Boehringer Ingelheim Pharmaceuticals, Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for 1199SEIU National Benefit Fund v. Boehringer Ingelheim Pharmaceuticals, Inc. (D. Conn. 2024)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2024-04-29	1	Complaint	Unexpired Device-Only Patent 1: U.S. Patent No. 7,284,474 (the ’474 patent) claims a piston-pumping…tiotropium)—the ’474 patent, the ’341 patent, the ’235 patent, the ’264 patent, the ’3,341 patent, and the ’967…of 191 patent (U.S. Patent No. 6,988,496), “Cartridge for a liquid” patent (U.S. Patent No. 7,802,…notify the FDA to amend the patent information or withdraw the patent or patent information.”34 …the “Patent Listing Form”) when submitting a patent for listing in the Orange Book. 36 The Patent Listing	External link to document
2024-07-16	37	Exhibit B	United States Patent Nos. 7,284,474 (“the ’474 patent”), 7,896,264 (“the ’264 patent”), 7,396,341 (“…(“the ’6,341 patent”), 9,027,967 (“the ’967 patent”), 7,837,235 (“the ’235 patent”), and 8,733,341 (“… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…(“the ’3,341 patent”) (collectively, “the patents-in-suit”). Plaintiffs seek injunctive relief against…purports to assert an action for patent infringement pursuant to the patent laws of the United States, 35	External link to document
2024-07-17	38	Amended Complaint	Unexpired Device-Only Patent 1: U.S. Patent No. 7,284,474 (the ’474 patent) claims a piston-pumping…tiotropium)—the ’474 patent, the ’341 patent, the ’235 patent, the ’264 patent, the ’3,341 patent, and the ’967…: the ’474 patent, the ’341 patent, the ’235 patent, the ’264 patent, and the ’967 patent.153 …of 192 patent (U.S. Patent No. 6,988,496), “Cartridge for a liquid” patent (U.S. Patent No. 7,802,…notify the FDA to amend the patent information or withdraw the patent or patent information.”34	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.